J B Whitmore

Summary

Affiliation: Immunex Corporation
Country: USA

Publications

  1. ncbi request reprint Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials
    J B Whitmore
    Immunex Corporation, Seattle, WA 98101 2936, USA
    Support Care Cancer 6:473-8. 1998

Collaborators

Detail Information

Publications1

  1. ncbi request reprint Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials
    J B Whitmore
    Immunex Corporation, Seattle, WA 98101 2936, USA
    Support Care Cancer 6:473-8. 1998
    ....